B-Cell Receptor Signaling and Beyond: The Role of Igα (CD79a)/Igβ (CD79b) in Normal and Malignant B Cells
International Journal of Molecular Sciences · 19.12.2023 · 25 (1) · 10
DOI: 10.3390/ijms25010010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.12.2023. Verfasst von Anton Tkachenko und 2 weiteren Autor:innen. Beteiligte Einrichtung: BIOCEV, First Faculty of Medicine, Charles University, Prumyslova 595, 252 50 Vestec, Czech Republic. Hauptthemen laut MEDLINE: Receptors, Antigen, B-Cell, Signal Transduction. Die Arbeit wurde bisher 94-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Czech Health Research Council, Charles University in Prague, European Union - Next Generation EU.
Abstract (Originalsprache)
B-cell receptor (BCR) is a B cell hallmark surface complex regulating multiple cellular processes in normal as well as malignant B cells. Igα (CD79a)/Igβ (CD79b) are essential components of BCR that are indispensable for its functionality, signal initiation, and signal transduction. CD79a/CD79b-mediated BCR signaling is required for the survival of normal as well as malignant B cells via a wide signaling network. Recent studies identified the great complexity of this signaling network and revealed the emerging role of CD79a/CD79b in signal integration. In this review, we have focused on functional features of CD79a/CD79b, summarized signaling consequences of CD79a/CD79b post-translational modifications, and highlighted specifics of CD79a/CD79b interactions within BCR and related signaling cascades. We have reviewed the complex role of CD79a/CD79b in multiple aspects of normal B cell biology and how is the normal BCR signaling affected by lymphoid neoplasms associated CD79A/CD79B mutations. We have also summarized important unresolved questions and highlighted issues that remain to be explored for better understanding of CD79a/CD79b-mediated signal transduction and the eventual identification of additional therapeutically targetable BCR signaling vulnerabilities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BIOCEV, First Faculty of Medicine, Charles University, Prumyslova 595, 252 50 Vestec, Czech Republic.
- First Department of Internal Medicine-Hematology, General University Hospital and First Faculty of Medicine, Charles University, 128 08 Prague, Czech Republic.
ORCID-Profile: Anton Tkachenko, Kristyna Kupcova, Ondrej Havranek
Förderung
- Czech Health Research Council
- Charles University in Prague
- European Union - Next Generation EU
- European Hematology Association
- Charles University, Prague
- European Union—Next Generation EU
Zitieren
APA
Tkachenko, A., Kupcova, K., & Havranek, O. (2023). B-Cell Receptor Signaling and Beyond: The Role of Igα (CD79a)/Igβ (CD79b) in Normal and Malignant B Cells. International Journal of Molecular Sciences, 25(1), 10. https://doi.org/10.3390/ijms25010010
Vancouver
Tkachenko A, Kupcova K, Havranek O. B-Cell Receptor Signaling and Beyond: The Role of Igα (CD79a)/Igβ (CD79b) in Normal and Malignant B Cells. International Journal of Molecular Sciences. 2023;25(1):10. doi:10.3390/ijms25010010
BibTeX
@article{Tkachenko2023,
author = {Tkachenko, Anton and Kupcova, Kristyna and Havranek, Ondrej},
title = {B-Cell Receptor Signaling and Beyond: The Role of Igα (CD79a)/Igβ (CD79b) in Normal and Malignant B Cells},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {25},
number = {1},
pages = {10},
doi = {10.3390/ijms25010010}
}
EUVIMED